MeSH D004427 - ear diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010038:Otorhinolaryngologic diseases
0 Companies
0 Drugs
Success rate
D004427:Â
Ear diseases
D000081015:Ototoxicity
D004426:Acquired ear deformities
0 Companies
0 Drugs
Success rate
D004428:Ear neoplasms
0 Companies
0 Drugs
Success rate
D004433:Earache
0 Companies
0 Drugs
Success rate
D006311:Hearing disorders
0 Companies
0 Drugs
Success rate
D007759:Labyrinth diseases
0 Companies
0 Drugs
Success rate
D010031:Otitis
0 Companies
0 Drugs
Success rate
D010040:Otosclerosis
0 Companies
0 Drugs
Success rate
D012181:Retrocochlear diseases
0 Companies
0 Drugs
Success rate
D016697:Herpes zoster oticus
0 Companies
0 Drugs
Success rate
D018058:Tympanic membrane perforation
0 Companies
0 Drugs
Success rate
D018424:Middle ear cholesteatoma
0 Companies
0 Drugs
Success rate
D055955:Susac syndrome
0 Companies
0 Drugs
Success rate
D065817:Congenital microtia
0 Companies
0 Drugs
Success rate
D000092163:Tympanosclerosis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Genus Lifesciences | Prednisolone, Sulfacetamide | Sulfacetamide Prednisolone |  | 1993-05-27 |  |  |
| Novartis | Prednisolone, Sulfacetamide | Vasocidin |  | 1984-10-05 |  |  |
| Bausch Health Companies | Prednisolone, Sulfacetamide | Sulfacetamide Prednisolone |  | 1995-12-29 |  |  |
| Prednisolone, Sulfacetamide | Sulphrin |  | 1982-12-28 |  |  | |
| Merck & Co | Prednisolone, Sulfacetamide | Metimyd |  | 1982-01-01 |  |  |
| Pseudoephedrine, Azatadine | Trinalin |  | 1982-03-23 |  |  | |
| Allergan | Prednisolone, Sulfacetamide | Blephamide |  | 1986-12-03 |  |  |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
100%3/3
Phase 2
0%0/4
Phase 3
100%1/1
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use